SEER Inquiry System - Home

Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.

Recent Questions
1 to 10 of 1931    Next 10 >    Last >>
Add to Report ID Question Status Last Updated

MP/H Rules/Histology--Colon:  Is the code for invasive adenocarcinoma in a serrated adenoma 8213/3?  The NAACCR Guidelines for ICD-O-3 Update Implementation, effective 1/1/14, provides new terms including 8213/0 for sessile serrated adenoma/sessile serrated polyp and 8213/3 for serrated adenocarcinoma. This would cause Site/Type and Histology overrides to be set. Coding 8210/3 would allow the case to be reported without overrides.  See Discussion.

Final Feb 15 2017

Heme & Lymphoid Neoplasms/Diagnostic confirmation--Lymphoma: To code "3" in Diagnostic Confirmation, does the genetic testing need to confirm a specific histology or is it enough that is simply rules out others?  See Discussion.

Final Feb 02 2017

Reportability/Histology--Testis: Is neoplasm consistent with carcinoid type of monodermal teratoma reportable as a teratoma, NOS, and if yes, what is the histology code?

Final Jan 31 2017

MP/H Ruels/Histology--Kidney/renal pelvis: How is MiT family translocation renal cell carcinoma (RCC) with Xp11 translocation coded? See Discussion.

Final Jan 31 2017

Reportability/Histology--Brain and CNS: Is epidermoid tumor of the cerebellopontine angle (CPA) and trigeminal vesicle nerve reportable, and if so, what is the correct histology code? See discussion.

Final Jan 31 2017

Reportability--Brain and CNS: Are cavernous sinus meningiomas reportable? See Discussion.


Final Jan 18 2017

MP/H Rules/Histology--Kidney: How is the histology coded and what rule(s) apply to the classification of succinate dehydrogenase-deficient renal cell carcinoma? See Discussion.

Final Jan 17 2017

First course treatment/Chemotherapy: Is metronomic chemotherapy coded as chemotherapy?

Final Dec 20 2016

First course treatment/Radiation Therapy--Prostate: How do you code fiducial markers for prostate cases?

Final Dec 20 2016

First course treatment/Immunotherapy--Prostate:  Is XGEVA, given for bone mets from prostate cancer, abstracted as immunotherapy, or is it an ancillary drug and not recorded?

Final Dec 20 2016
Next 10 >